¡¡
July 4, 2006 (Tuesday, Mandarin Hall)
8:30-8:45
Welcome Address
8:45-10:15
Topic I (Peptide Mimetics and Drug
Design)
Chairpersons:
James
P Tam & Jiecheng Xu
Time
|
Speaker
|
Title
|
8:45-9:15
|
Victor
J. Hruby
|
Design
of bifunctional ligands for disease: neuropathic pain (IL-01)
|
9:15-9:45
|
Yoshiaki
Kiso
|
Challenging
intractable diseases: protease inhibitors and O¨CN
acyl migration-type prodrug forms (IL-02)
|
9:45-10:15
|
Shaomeng
Wang
|
Design
of Smac mimetics as a new class of anticancer drugs (IL-03)
|
10:15-10:30
Coffee Break
10:30-12:00
Topic I (Peptide Mimetics and Drug Design)
Chairpersons:
Saburo
Aimoto & Ziwei Huang
Time
|
Speaker
|
Title
|
10:30-11:00
|
Kit
S Lam
|
From
combinatorial chemistry to cancer targeting agents (IL-04)
|
11:00-11:30
|
Richard
A. Houghten
|
The
use of combinatorial libraries for drug discovery (IL-05)
|
11:30-11:50
|
Luna
Liu
|
Improved peptide
synthesis results through control of interfering solvent impurities and
reagent composition (OP-01)
|
12:00-13:00
Lunch Break
Session
I: Peptide Chemistry (Mandarin Hall)
13:00-14:00
Topic II (Methodology)
Chairpersons:
Jun
Shao & Jiaxi Xu
Time
|
Speaker
|
Title
|
13:00-13:30
|
Xumu
Zhang
|
Preparation
of chiral alpha, beta and cyclic amino acids for peptide synthesis through
practical asymmetric hydrogenation (IL-06)
|
13:30-14:00
|
Yanxing
Jia
|
Design
and synthesis of analogues of vancomycin binding pocket active against
vancomycin- resistant enterococci (VRE) (IL-07)
|
14:00-15:30
Oral Presentations (Peptide Chemistry)
Chairpersons:
Hueih-Min Chen &
Ning-Hua Tan
Time
|
Speaker
|
Title
|
14:00-14:15
|
Ya-Qiu
Long
|
Discovery of a new
class of potent peptidomimetic antagonists of the grb2-SH2 domain by the
simultaneous utilization of 3¡¯-substituted tyrosine and a,a-disubstituted
amino acid (OP-03)
|
14:15-14:30
|
Y.
Okada
|
Unique and potent
¦Ì-opioid agonists and antagonists for application to therapeutics (OP-04)
|
14:30-14:45
|
Michael
R. Carrasco
|
"Post-translational"
modification of synthetic peptides by chemoselective alkylation of N-alkylaminooxy
amino acids (OP-05)
|
14:45-15:00
|
Jia-Xi
Xu
|
Synthesis of
structurally diverse 2-aminoalkanesulfonic acids for synthesis of
sulfonopeptides (OP-06)
|
15:00-15:15
|
J.
J. Jiang
|
Synthesis of
conotoxin MII and derivatives via one-pot double disulfide oxidative
refolding (OP-07)
|
15:15-15:30
|
Zhen
Pang
|
Synthesis of small
peptides and their use as bifunctional chelating agents in diagnostic
radiopharmaceuticals (OP-08)
|
15:30-15:45
Coffee Break
15:45-18:15
Oral Presentations (Peptide Chemistry)
Chairpersons:
Ya-Qiu Long & J. J.
Jiang
Time
|
Speaker
|
Title
|
15:45-16:00
|
J.
M. Collins
|
Expanding
application and scale of microwave enhanced solid phase peptide synthesis
(OP-09)
|
16:00-16:15
|
Sulan
Luo
|
Development of
solid-phase peptide synthesis in marine medicine (OP-10)
|
16:15-16:30
|
Koushi
Hidaka
|
Peptidemimetics
with high affinity to malarial aspartic protease plasmepsin II (OP-11)
|
16:30-16:45
|
Ye
Yu
|
Development of
potent endomorphins analogs using a typical conformationally and
topographically constrained C-terminus (OP-12)
|
16:45-17:00
|
Ning-Hua
Tan
|
Cyclopeptides in
plants (OP-13)
|
17:00-17:15
|
Qiuyun
Dai
|
Design of a novel
peptidic HIV-1 fusion inhibitor against drug-resistant viruses (OP-14)
|
17:15-17:30
|
Hueih-Min
Chen
|
A custom
anti-cancer peptide, CB1a, derived from a natural anti-microbial peptide,
cecopin B (OP-15)
|
17:30-17:45
|
Pu
Wang
|
New special
reagents: their synthesis and application in peptide and protein chemical
syntheses (OP-16)
|
17:45-18:00
|
P.
W. Schiller
|
Novel opioid
peptide derived antagonists containing 3-(2,6-dimethyl-4-carbamoyl)
propanoic acid (Dcp) in place of Tyr1 (OP-17)
|
Session II: Peptide
Biology (3C + 3D Hall)
13:00-14:00
Topic III (Peptides and Receptors)
Chairpersons:
Kyung-Soo
Hahm & Zhongwu Guo
Time
|
Speaker
|
Title
|
13:00-13:30
|
Songping
Liang
|
A
spider peptide toxin targeting both serine proteinase and potassium
channels (IL-08)
|
13:30-14:00
|
Minying
Cai
|
Study
of peptide vs non-peptide agonists effects on postranslational
modifications of the human melanocortin 4 receptor (IL-09)
|
14:00-15:30
Oral Presentations (Peptide Biology)
Chairpersons:
Minying
Cai & Songping Liang
Time
|
Speaker
|
Title
|
14:00-14:15
|
Hong-Yu
Hu
|
The effects of GAV
homologous peptides on aggregation of a-synuclein
(OP-18)
|
14:15-14:30
|
L.V.
Kordyukova
|
Influenza virus
membrane proteins: studying by proteomic tools (OP-19)
|
14:30-14:45
|
Liang
Zeng Yan
|
Structure-activity
relationship of a-MSH
derived melanocortin-4 receptor agonists and its potential use as an
anti-obesity agent (OP-20)
|
14:45-15:00
|
Alexander
A. Zamyatnin
|
Structural and
functional diversity of the natural oligopeptides (OP-21)
|
15:00-15:15
|
Minfen
Li
|
Structural
characterization of the human Nogo functional domains and molecular design
to enhance the CNS neuronal regeneration (OP-22)
|
15:15-15:30
|
Jaw-Kang
Chang
|
Insulin-like
peptide 5: synthesis, expression in the mouse brain and mobilization of
calcium (OP-23)
|
15:30-15:45
Coffee Break
15:45-18:00
Oral Presentations (Peptide Biology)
Chairpersons:
Hong-Yu Hu & L.V.
Kordyukova
Time
|
Speaker
|
Title
|
15:45-16:00
|
Beka
Solomon
|
EFRH peptide
immunization restored cognitive functions to hAPP transgenic mice model of
Alzheimer's disease (OP-24)
|
16:00-16:15
|
Bih-Show
Lou
|
Probing the
interaction of Na+ channel inactivation gate peptide in linker
between domain III and IV during inactivation by using NMR and ESI-MS
spectrometry (OP-25)
|
16:15-16:30
|
Hazel
H. Szeto
|
Cell-permeable,
mitochondria-targeted antioxidant peptides are potent neuroprotective
agents (OP-26)
|
16:30-16:45
|
Magdalena
Witt
|
Molecular
simulations of the rhodopsin tetramer (OP-27)
|
16:45-17:00
|
Shaoying
Wen
|
A
study of the interaction of natural antimicrobial peptides with bacterial
model membrane (OP-28)
|
17:00-17:15
|
Jun
Lu
|
Protonation-mediated
structural flexibility in the F conjugation regulatory protein, TraM (OP-29)
|
17:15-17:30
|
A.J.P.
ALIX
|
Morpho-matrikines :
a new concept for treating the 3D interactions of matrikines from the ECM:
Applications to analogues of elastin and collagen bioactive derived
peptides (OP-30)
|
17:30-17:45
|
Per
Jageland
|
Reversed phase HPLC
purification of peptides ¨C a case study (OP-31)
|
17:45-18:00
|
Ting
(Ginger) Chen
|
Discovery and
characterization of human antibody inhibitors of pregnancy- associated
plasma protein-A (PAPP-A) using internally quenched synthetic peptide
substrates (OP-32)
|
18:30-20:00
Dinner
20:00-21:30
Poster Presentations & Discussions
July 5, 2006 (Wednesday, Mandarin
Hall)
8:15-10:15
Topic IV (Synthesis: Large Peptides)
Chairpersons:
Ian
Smith & Yoshiaki Kiso
Time
|
Speaker
|
Title
|
8:15-8:45
|
James
P Tam
|
Cyclic
cystine-rich peptides
(IL-10)
|
8:45-9:15
|
Zhongwu
Guo
|
Solution-phase
glycopeptide synthesis with solid-phase workup (IL-11)
|
9:15-9:45
|
Saburo
Aimoto
|
Use
of N-S acyl shift reaction for peptide thioester preparation (IL-12)
|
9:45-10:15
|
Masahiko
Sisido
|
tRNA
Aminoacylation Using Peptide Nucleic Acid as a Carrier of Amino Acid
Esters
(IL-13)
|
10:15-10:30
Coffee Break
10:30-11:50
Topic V (Analysis and Biofunctions)
Chairpersons:
John
D. Wade & B. Moon Kim
Time
|
Speaker
|
Title
|
10:30-11:00
|
Naoto
Minamino
|
Peptidome
database and identification of new biologically active peptides (IL-14)
|
11:00-11:30
|
Rong
Zeng
|
Detection
of phosphorylated peptides with two-dimensional liquid chromatography mass
spectrometry (IL-15)
|
11:30-12:00
|
Hisakazu
Mihara
|
Designed peptide
microarrays for protein analyses (IL-16)
|
12:00-13:00
Lunch Break
13:00-18:00
Tour
July
6, 2006 (Thursday, Mandarin
Hall)
8:15-10:15
Topic VI (Peptide Biology & SignalingChairpersons:
Jean
Martinez &
Hisakazu Mihara
Time
|
Speaker
|
Title
|
8:15-8:45
|
Ian
Smith
|
Cryptomics:
identification of novel bioactive peptides from intact proteins (IL-17)
|
8:45-9:15
|
B.
Moon Kim
|
Development
of peptide secondary structure mimics capable of reversible structural
change through a molecular switch (IL-18)
|
9:15-9:45
|
John
D. Wade
|
Structure-function
relationships and domain minimization of insulin-like peptide 3, a novel
member of the insulin superfamily (IL-19)
|
9:45-10:15
|
Rob
M. J. Liskamp
|
Tools
for conformational control of peptides and mimicry of proteins: ring
closing metathesis and scaffolding (IL-20)
|
10:15-10:30
Coffee Break
10:30-11:50
Topic VI (Peptide Biology & Signaling)
Chairpersons:
P. W. Schiller &
Yanmei Li
Time
|
Speaker
|
Title
|
10:30-11:00
|
Wentworth
Jr
|
Inflammatory
aldehyde triggered protein misfolding-implications from alzheimer¡¯s
disease to cancer (IL-21)
|
11:00-11:30
|
Kyung-Soo
Hahm
|
A
Molecular Mechanism of Pore Formation by Amphipathic ¦Á-Helical
Peptides in
Lipid Membranes (IL-22)
|
11:30-11:50
|
Aubrey
J. Mendonca
|
Polymer based
synthesis and purification of peptides (OP-02)
|
12:00-13:00
Lunch Break
13:00-14:00
Topic VI (Peptide Biology & Signaling)
Chairpersons:
Keliang Liu &
Mark
Lipton
Time
|
Speaker
|
Title
|
13:00-13:30
|
Yan-Mei
Li
|
The
effects of O-phosphorylation and O-glcN- Acylation on protein structure
and function (IL-23)
|
13:30-14:00
|
David
J Craik
|
Structure-activity
relationships and anti-HIV activity of cyclotides (IL-24)
|
14:00-15:10
Special Session for
Cathay
Award
Chairpersons:
Kit
S Lam & Yunhua Ye
Time
|
Speaker
|
Title
|
14:00-14:35
|
Jean
Martinez
|
On
the use of N-carboxyanhydrides as interesting starting materials in
organic synthesis (IL-25)
|
14:35-15:10
|
Keliang
Liu
|
Design,
synthesis and mechanism studies of long-acting peptides against protease
degradation (IL-26)
|
15:10-15:25
Coffee Break
15:25-17:25
Topic VII (Synthesis: Small Peptides)
Chairpersons:
Victor
J. Hruby & Rui Wang
Time
|
Speaker
|
Title
|
15:25-15:55
|
Takayuki
Shioiri
|
Some
problems on the synthesis of biologically active cyclic peptides and
depsipeptides of aquatic origin
(IL-27)
|
15:55-16:25
|
Madeleine
M. Joulli¨¦
|
Synthetic
investigations of antimitotic agents (IL-28)
|
16:25-16:55
|
Mark
Lipton
|
Solid-phase
synthesis and mode of action studies of the cyclic depsipeptides
callipeltins A and B (IL-29)
|
16:55-17:25
|
Zhu-Jun
Yao
|
Studies
on total synthesis of chlorofusin, a naturally occurring p53-MDM2
interaction inhibitor (IL-30)
|
17:25
Award Ceremony and Closing Remarks
18:30
Farewell Banquet
¡¡ |